Dr Choudary V Tarigopula, MD | |
222 S Woods Mill Rd Ste 450s, Chesterfield, MO 63017-3625 | |
(314) 205-2733 | |
(314) 434-6476 |
Full Name | Dr Choudary V Tarigopula |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 46 Years |
Location | 222 S Woods Mill Rd Ste 450s, Chesterfield, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558450718 | NPI | - | NPPES |
P00080017 | Other | RAILROAD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 103774 (Missouri) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Lukes Hospital | Chesterfield, MO | Hospital |
Entity Name | Midwest Diagnostic Cardiology, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457467755 PECOS PAC ID: 5991739757 Enrollment ID: O20050921000355 |
News Archive
Childhood obesity is on the rise in China, and children and parents there tend to underestimate body weight, according to Penn State health policy researchers.
It's no surprise that children from low socioeconomic backgrounds may be at risk for numerous health problems in the future. Scientists speculate that these health problems, including increased risk for depression, anxiety and substance abuse, arise from the physiological toll that the environment has on the children's bodies.
Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.
About 1 in 200 women in the US delivers her baby at home, with approximately 75% of these low-risk, single-baby births planned in advance as home deliveries. In a study published online today by the American Journal of Obstetrics & Gynecology (AJOG), researchers from Maine Medical Center, Portland, Maine, analyzed the results of multiple studies from around the world.
Hard to Treat Diseases (HTDS.PK) Dr. Sanja Pekovic, Chief Project Scientist, Chief Strategy Officer Slavica BioChem reported that IBISS research group from Serbia has begun preliminary experiments within a project aimed at Promoting stem cell graft survival in the model of traumatic brain injury in rats.
› Verified 4 days ago
Entity Name | Physician Specialists Of St Lukes Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235168410 PECOS PAC ID: 1557366960 Enrollment ID: O20060918000462 |
News Archive
Childhood obesity is on the rise in China, and children and parents there tend to underestimate body weight, according to Penn State health policy researchers.
It's no surprise that children from low socioeconomic backgrounds may be at risk for numerous health problems in the future. Scientists speculate that these health problems, including increased risk for depression, anxiety and substance abuse, arise from the physiological toll that the environment has on the children's bodies.
Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.
About 1 in 200 women in the US delivers her baby at home, with approximately 75% of these low-risk, single-baby births planned in advance as home deliveries. In a study published online today by the American Journal of Obstetrics & Gynecology (AJOG), researchers from Maine Medical Center, Portland, Maine, analyzed the results of multiple studies from around the world.
Hard to Treat Diseases (HTDS.PK) Dr. Sanja Pekovic, Chief Project Scientist, Chief Strategy Officer Slavica BioChem reported that IBISS research group from Serbia has begun preliminary experiments within a project aimed at Promoting stem cell graft survival in the model of traumatic brain injury in rats.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Choudary V Tarigopula, MD 222 S Woods Mill Rd Ste 450s, Chesterfield, MO 63017-3625 Ph: (314) 205-2733 | Dr Choudary V Tarigopula, MD 222 S Woods Mill Rd Ste 450s, Chesterfield, MO 63017-3625 Ph: (314) 205-2733 |
News Archive
Childhood obesity is on the rise in China, and children and parents there tend to underestimate body weight, according to Penn State health policy researchers.
It's no surprise that children from low socioeconomic backgrounds may be at risk for numerous health problems in the future. Scientists speculate that these health problems, including increased risk for depression, anxiety and substance abuse, arise from the physiological toll that the environment has on the children's bodies.
Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.
About 1 in 200 women in the US delivers her baby at home, with approximately 75% of these low-risk, single-baby births planned in advance as home deliveries. In a study published online today by the American Journal of Obstetrics & Gynecology (AJOG), researchers from Maine Medical Center, Portland, Maine, analyzed the results of multiple studies from around the world.
Hard to Treat Diseases (HTDS.PK) Dr. Sanja Pekovic, Chief Project Scientist, Chief Strategy Officer Slavica BioChem reported that IBISS research group from Serbia has begun preliminary experiments within a project aimed at Promoting stem cell graft survival in the model of traumatic brain injury in rats.
› Verified 4 days ago
Lovepreet Singh Randhawa, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 224 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-205-6050 Fax: 314-205-6350 | |
Rachel Lynn Fishman Oiknine, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 222 S Woods Mill Rd, Suite 410n, Chesterfield, MO 63017 Phone: 314-469-6224 Fax: 314-469-0744 | |
Xiaoling Wu, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 224 S Woods Mill Rd, Suite 370 South, Chesterfield, MO 63017 Phone: 314-878-2460 | |
Daniel B Bauwens, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 232 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-576-5023 | |
Michael Carl Fusco, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 14528 S Outer 40, Suite 300, Chesterfield, MO 63017 Phone: 314-214-8100 Fax: 314-214-8233 | |
David H Cort, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 226 S Woods Mill Rd, Suite 52 West, Chesterfield, MO 63017 Phone: 314-434-2399 Fax: 314-434-5653 | |
Meghashyam Jayateerth Koti, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 15740 S Outer 40 Rd # C, Chesterfield, MO 63017 Phone: 636-735-4963 |